Social prescribing for at reducere polyfarmaci ved KOL i almen praksis

Dea Kejlberg Andelius*, Nanna Holt Jessen, Anders Løkke Ottesen, Rasmus Østergaard Nielsen, Julie Sandell Jacobsen


Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


Patients suffering from COPD are often treated with a substantial number of medications due to multimorbidity. The combination of multimorbidity and polypharmacy can make the treatment of individuals with COPD difficult. Although guidelines in recent years have focused on the reduction of inappropriate medication, there is still room for improvement. This review suggests an increased focus on smoking cessation and physical activity in terms of the use of social prescribing to prevent polypharmacy and thereby improve sustainability in patients with COPD.
Bidragets oversatte titelSocial prescribing to reduce polypharmacy in patients with COPD in general practice
TidsskriftUgeskrift for Læger
Udgave nummer20A
StatusUdgivet - 16. okt. 2023


  • Drug-Related Side Effects and Adverse Reactions
  • General Practice
  • Humans
  • Inappropriate Prescribing/prevention & control
  • Polypharmacy
  • Pulmonary Disease, Chronic Obstructive/drug therapy


Dyk ned i forskningsemnerne om 'Social prescribing for at reducere polyfarmaci ved KOL i almen praksis'. Sammen danner de et unikt fingeraftryk.